Document:

Exhibit 10.2

 

INDEMNIFICATION AGREEMENT

 

This Agreement made and entered into this 22nd day of July, 2008 (the “Agreement”),
by and between NeuroMetrix, Inc., a Delaware corporation (the “Company,”
which term shall include, where appropriate, any Entity (as hereinafter
defined) controlled directly or indirectly by the Company) and Joseph A. Calo
(the “Indemnitee”):

 

WHEREAS, the Company desires to retain the Indemnitee to serve as a
consultant to the Company in the role of principal financial officer and principal
accounting officer;

 

WHEREAS, increased corporate litigation has subjected persons serving
in such roles to litigation risks and expenses, and the limitations on the
availability of directors and officers liability insurance have made it
increasingly difficult for the Company to attract and retain such persons;

 

WHEREAS, the Company’s By-laws
(the “By-laws”) require it to indemnify certain persons associated with
the Company and permit it to make other indemnification arrangements and
agreements;

 

WHEREAS, the Company desires to provide Indemnitee with specific
contractual assurance of Indemnitee’s rights to full indemnification against
litigation risks and expenses (regardless, among other things, of any amendment
to or revocation of the By-laws
or any change in the ownership of the Company);

 

WHEREAS, the Company intends that this Agreement provide Indemnitee
with greater protection than that which is provided by the Company’s By-laws; and

 

WHEREAS, Indemnitee is relying upon the rights afforded under this
Agreement in  becoming  a
consultant to the Company in the role of principal financial officer and
principal accounting officer.

 

NOW, THEREFORE, in consideration of the promises and the covenants
contained herein, the Company and Indemnitee do hereby covenant and agree as
follows:

 

1.                                       Definitions.

 

(a)                                  “Corporate Status” describes the status
of a person who is serving or has served (i) as a consultant to the
Company in the role of principal financial officer and principal accounting
officer,  (ii) in any capacity
with respect to any employee benefit plan of the Company, or (iii) as a
director, partner, trustee, officer, employee, or agent of any other Entity at
the request of the Company.  For purposes
of subsection (iii) of this Section 1(a), if Indemnitee  is serving or has served as a director,
partner, trustee, officer, employee or agent of a Subsidiary, Indemnitee shall
be deemed to be serving at the request of the Company.

 

 

(b)                                 “Entity” shall mean any corporation,
partnership, limited liability company, joint venture, trust, foundation,
association, organization or other legal entity.

 

(c)                                  “Expenses” shall mean all fees, costs and
expenses incurred by Indemnitee in connection with any Proceeding (as defined
below), including, without limitation, attorneys’ fees, disbursements and
retainers (including, without limitation, any such fees, disbursements and
retainers incurred by Indemnitee pursuant to Sections 10 and 11(c) of
this Agreement), fees and disbursements of expert witnesses, private investigators
and professional advisors (including, without limitation, accountants and
investment bankers), court costs, transcript costs, fees of experts, travel
expenses, duplicating, printing and binding costs, telephone and fax
transmission charges, postage, delivery services, secretarial services, and
other disbursements and expenses.

 

(d)                                 “Indemnifiable Expenses,” “Indemnifiable
Liabilities” and “Indemnifiable Amounts” shall have the meanings ascribed to
those terms in Section 3(a) below.

 

(e)                                  “Liabilities” shall mean judgments,
damages, liabilities, losses, penalties, excise taxes, fines and amounts paid
in settlement.

 

(f)                                    “Proceeding” shall mean any threatened,
pending or completed claim, action, suit, arbitration, alternate dispute
resolution process, investigation, administrative hearing, appeal, or any other
proceeding, whether civil, criminal, administrative, arbitrative or
investigative, whether formal or informal, including a proceeding initiated by
Indemnitee pursuant to Section 10 of this Agreement to enforce Indemnitee’s
rights hereunder.

 

(g)                                 “Subsidiary” shall mean any corporation,
partnership, limited liability company, joint venture, trust or other Entity of
which the Company owns (either directly or through or together with another
Subsidiary of the Company) either (i) a general partner, managing member
or other similar interest or (ii) (A) 50% or more of the voting power
of the voting capital equity interests of such corporation, partnership,
limited liability company, joint venture or other Entity, or (B) 50% or
more of the outstanding voting capital stock or other voting equity interests
of such corporation, partnership, limited liability company, joint venture or
other Entity.

 

2.                                       Services of
Indemnitee.  In
consideration of the Company’s covenants and commitments hereunder, Indemnitee
agrees to serve or continue to serve as a consultant to the Company in the role of principal financial
officer and principal accounting officer.  However, this Agreement shall not impose any
obligation on Indemnitee or the Company to continue Indemnitee’s service to the
Company beyond any period otherwise required by law or by other agreements or
commitments of the parties, if any.

 

2

 

3.                                       Agreement to
Indemnify.  The
Company agrees to indemnify Indemnitee as follows:

 

(a)                                  Proceedings Other Than By or In the Right
of the Company.  Subject to the exceptions contained in Section 4(a) below,
if Indemnitee was or is a party or is threatened to be made a party to any Proceeding
(other than an action by or in the right of the Company) by reason of
Indemnitee’s Corporate Status, Indemnitee shall be indemnified by the Company
against all Expenses and Liabilities incurred or paid by Indemnitee in
connection with such Proceeding (referred to herein as “Indemnifiable Expenses”
and “Indemnifiable Liabilities,” respectively, and collectively as “Indemnifiable
Amounts”).

 

(b)                                 Proceedings By or In the Right of the
Company.  Subject to the exceptions contained in Section 4(b) below,
if Indemnitee was or is a party or is threatened to be made a party to any
Proceeding by or in the right of the Company by reason of Indemnitee’s
Corporate Status, Indemnitee shall be indemnified by the Company against all
Indemnifiable Expenses.

 

(c)                                  Conclusive Presumption Regarding Standard
of Care.  In making any determination required to be
made under Delaware law with respect to entitlement to indemnification
hereunder, the person, persons or entity making such determination shall
presume that Indemnitee is entitled to indemnification under this Agreement if
Indemnitee submitted a request therefor in accordance with Section 5 of
this Agreement, and the Company shall have the burden of proof to overcome that
presumption in connection with the making by any person, persons or entity of
any determination contrary to that presumption.

 

4.                                       Exceptions to
Indemnification.  Indemnitee
shall be entitled to indemnification under Sections 3(a) and 3(b) above
in all circumstances other than with respect to any specific claim, issue or
matter involved in the Proceeding out of which Indemnitee’s claim for
indemnification has arisen, as follows:

 

(a)                                  Proceedings Other Than By or In the Right
of the Company.  If indemnification is requested under Section 3(a) and
it has been finally adjudicated by a court of competent jurisdiction that, in
connection with such specific claim, issue or matter, Indemnitee failed to act (i) in
good faith and (ii) in a manner Indemnitee reasonably believed to be in or
not opposed to the best interests of the Company, or, with respect to any
criminal Proceeding, Indemnitee had reasonable cause to believe that Indemnitee’s
conduct was unlawful, Indemnitee shall not be entitled to payment of
Indemnifiable Amounts hereunder.

 

(b)                                 Proceedings By or In the Right of the
Company.  If indemnification is requested under Section 3(b) and

 

(i)                                     it has been finally adjudicated by a
court of competent jurisdiction that, in connection with such specific claim,
issue or matter, Indemnitee failed to act (A) in good faith and (B) in
a manner Indemnitee reasonably 

 

3

 

believed to be in or not opposed to the best interests
of the Company, Indemnitee shall not be entitled to payment of Indemnifiable
Expenses hereunder; or

 

(ii)                                  it has been finally adjudicated by a
court of competent jurisdiction that Indemnitee is liable to the Company with
respect to such specific claim, Indemnitee shall not be entitled to payment of
Indemnifiable Expenses hereunder with respect to such claim, issue or matter
unless the Court of Chancery or another court in which such Proceeding was
brought shall determine upon application that, despite the adjudication of
liability, but in view of all the circumstances of the case, Indemnitee is fairly
and reasonably entitled to indemnification for such Indemnifiable Expenses
which such court shall deem proper; or

 

(iii)                               it has been finally adjudicated by a court of
competent jurisdiction that Indemnitee is liable to the Company for an
accounting of profits made from the purchase or sale by the Indemnitee of
securities of the Company pursuant to the provisions of Section 16(b) of
the Securities Exchange Act of 1934, the rules and regulations promulgated
thereunder and amendments thereto or similar provisions of any federal, state
or local statutory law, Indemnitee shall not be entitled to payment of
Indemnifiable Expenses hereunder.

 

(c)                                  Insurance Proceeds. 
To the extent payment is actually made to the Indemnitee under a valid
and collectible insurance policy in respect of Indemnifiable Amounts in
connection with such specific claim, issue or matter, Indemnitee shall not be
entitled to payment of Indemnifiable Amounts hereunder except in respect of any
excess beyond the amount of payment under such insurance.

 

5.                                       Procedure for Payment of Indemnifiable
Amounts.  Indemnitee shall submit to the Company a
written request specifying the Indemnifiable Amounts for which Indemnitee seeks
payment under Section 3 of this Agreement and the basis for the
claim.  The Company shall pay such
Indemnifiable Amounts to Indemnitee within sixty (60) calendar days of receipt
of the request.  At the request of the
Company, Indemnitee shall furnish such documentation and information as are
reasonably available to Indemnitee and necessary to establish that Indemnitee
is entitled to indemnification hereunder.

 

6.                                       Indemnification for Expenses of a Party
Who is Wholly or Partly Successful.  Notwithstanding any other
provision of this Agreement, and without limiting any such provision, to the
extent that Indemnitee is, by reason of Indemnitee’s Corporate Status, a party
to and is successful, on the merits or otherwise, in any Proceeding, Indemnitee
shall be indemnified against all Expenses reasonably incurred by Indemnitee or
on Indemnitee’s behalf in connection therewith. 
If Indemnitee is not wholly successful in such Proceeding but is
successful, on the merits or otherwise, as to one or more but less than all
claims, issues or matters in such Proceeding, the Company shall indemnify Indemnitee
against all Expenses reasonably incurred by Indemnitee or on Indemnitee’s
behalf in connection with each successfully resolved claim, 

 

4

 

issue or matter.  For purposes of
this Agreement, the termination of any claim, issue or matter in such a
Proceeding by dismissal, with or without prejudice, by reason of settlement,
judgment, order or otherwise, shall be deemed to be a successful result as to
such claim, issue or matter.

 

7.                                       Effect of Certain Resolutions. 
Neither the settlement or termination of any Proceeding nor the failure
of the Company to award indemnification or to determine that indemnification is
payable shall create a presumption that Indemnitee is not entitled to
indemnification hereunder.  In addition,
the termination of any proceeding by judgment, order, settlement, conviction,
or upon a plea of nolo contendere or its equivalent shall not create a
presumption that Indemnitee did not act in good faith and in a manner which
Indemnitee reasonably believed to be in or not opposed to the best interests of
the Company or, with respect to any criminal Proceeding, had reasonable cause
to believe that Indemnitee’s action was unlawful.

 

8.                                       Agreement to Advance Expenses;
Undertaking.  The Company shall advance all Expenses
incurred by or on behalf of Indemnitee in connection with any Proceeding,
including a Proceeding by or in the right of the Company, in which Indemnitee
is involved by reason of such Indemnitee’s Corporate Status within ten (10) calendar
days after the receipt by the Company of a written statement from Indemnitee
requesting such advance or advances from time to time, whether prior to or
after final disposition of such Proceeding. 
To the extent required by Delaware law, Indemnitee hereby undertakes to
repay any and all of the amount of Indemnifiable Expenses paid to Indemnitee if
it is finally determined by a court of competent jurisdiction that Indemnitee
is not entitled under this Agreement to indemnification with respect to such
Expenses.  This  undertaking is an unlimited general
obligation of Indemnitee.

 

9.                                       Procedure for Advance Payment of Expenses. 
Indemnitee shall submit to the Company a written request specifying the
Indemnifiable Expenses for which Indemnitee seeks an advancement under Section 8
of this Agreement, together with documentation evidencing that Indemnitee has
incurred such Indemnifiable Expenses. 
Payment of Indemnifiable Expenses under Section 8 shall be made no
later than ten (10) calendar days after the Company’s receipt of such
request.

 

10.                                 Remedies of Indemnitee.

 

(a)                                  Right to Petition Court. 
In the event that Indemnitee makes a request for payment of
Indemnifiable Amounts under Sections 3 and 5 above or a request for an
advancement of Indemnifiable Expenses under Sections 8 and 9 above and the
Company fails to make such payment or advancement in a timely manner pursuant
to the terms of this Agreement, Indemnitee may petition the Court of Chancery
to enforce the Company’s obligations under this Agreement.

 

(b)                                 Burden of Proof. 
In any judicial proceeding brought under Section 10(a) above,
the Company shall have the burden of proving that Indemnitee is not entitled to
payment of Indemnifiable Amounts hereunder.

 

(c)                                  Expenses.  The Company
agrees to reimburse Indemnitee in full for any Expenses incurred by Indemnitee
in connection with investigating, preparing for, 

 

5

 

litigating, defending or
settling any action brought by Indemnitee under Section 10(a) above,
or in connection with any claim or counterclaim brought by the Company in
connection therewith, whether or not Indemnitee is successful in whole or in
part in connection with any such action.

 

(d)                                 Failure to Act Not a Defense. 
The failure of the Company (including its Board of Directors or any
committee thereof, independent legal counsel, or stockholders) to make a
determination concerning the permissibility of the payment of Indemnifiable
Amounts or the advancement of Indemnifiable Expenses under this Agreement shall
not be a defense in any action brought under Section 10(a) above, and
shall not create a presumption that such payment or advancement is not
permissible.

 

11.                                 Defense of the Underlying Proceeding.

 

(a)                                  Notice by Indemnitee. 
Indemnitee agrees to notify the Company promptly upon being served with
any summons, citation, subpoena, complaint, indictment, information, or other
document relating to any Proceeding which may result in the payment of
Indemnifiable Amounts or the advancement of Indemnifiable Expenses hereunder;
provided, however, that the failure to give any such notice shall not
disqualify Indemnitee from the right, or otherwise affect in any manner any
right of Indemnitee, to receive payments of Indemnifiable Amounts or
advancements of Indemnifiable Expenses unless the Company’s ability to defend
in such Proceeding is materially and adversely prejudiced thereby.

 

(b)                                 Defense by Company. 
Subject to the provisions of the last sentence of this Section 11(b) and
of Section 11(c) below, the Company shall have the right to defend Indemnitee
in any Proceeding which may give rise to the payment of Indemnifiable Amounts
hereunder; provided, however that the Company shall notify Indemnitee of any
such decision to defend within ten (10) calendar days of receipt of notice
of any such Proceeding under Section 11(a) above.  The Company shall not, without the prior
written consent of Indemnitee, consent to the entry of any judgment against
Indemnitee or enter into any settlement or compromise which (i) includes
an admission of fault of Indemnitee or (ii) does not include, as an
unconditional term thereof, the full release of Indemnitee from all liability
in respect of such Proceeding, which release shall be in form and substance
reasonably satisfactory to Indemnitee. 
This Section 11(b) shall not apply to a Proceeding brought by
Indemnitee under Section 10(a) above or pursuant to Section 19
below.

 

(c)                                  Indemnitee’s Right to Counsel. 
Notwithstanding the provisions of Section 11(b) above, if in a
Proceeding to which Indemnitee is a party by reason of Indemnitee’s Corporate
Status, (i) Indemnitee reasonably concludes that he or she may have
separate defenses or counterclaims to assert with respect to any issue which
may not be consistent with the position of other defendants in such Proceeding,
(ii) a conflict of interest or potential conflict of interest exists
between Indemnitee and the Company, or (iii) if the Company fails to
assume the 

 

6

 

defense of such
proceeding in a timely manner, Indemnitee shall be entitled to be represented
by separate legal counsel of Indemnitee’s choice at the expense of the
Company.  In addition, if the Company
fails to comply with any of its obligations under this Agreement or in the
event that the Company or any other person takes any action to declare this
Agreement void or unenforceable, or institutes any action, suit or proceeding
to deny or to recover from Indemnitee the benefits intended to be provided to
Indemnitee hereunder, Indemnitee shall have the right to retain counsel of
Indemnitee’s choice, at the expense of the Company, to represent Indemnitee in
connection with any such matter.

 

12.                                 Representations and Warranties of the
Company.  The Company hereby represents and warrants to
Indemnitee as follows:

 

(a)                                  Authority.  The Company
has all necessary power and authority to enter into, and be bound by the terms
of, this Agreement, and the execution, delivery and performance of the
undertakings contemplated by this Agreement have been duly authorized by the
Company.

 

(b)                                 Enforceability. 
This Agreement, when executed and delivered by the Company in accordance
with the provisions hereof, shall be a legal, valid and binding obligation of
the Company, enforceable against the Company in accordance with its terms,
except as such enforceability may be limited by applicable bankruptcy,
insolvency, moratorium, reorganization or similar laws affecting the
enforcement of creditors’ rights generally.

 

13.                                 Insurance.  The Company
shall, from time to time, make the good faith determination whether or not it
is practicable for the Company to obtain and maintain a policy or policies of
insurance with a reputable insurance company providing the Indemnitee with
coverage for losses from wrongful acts. 
For so long as Indemnitee shall remain a consultant to the Company in
the role of principal financial officer and principal accounting officer and
with respect to any such prior service, in all policies of director and officer
liability insurance, Indemnitee shall be named as an insured in such a manner
as to provide Indemnitee the same rights and benefits as are accorded to the
most favorably insured of the Company’s officers and directors.  Notwithstanding the foregoing, the Company
shall have no obligation to obtain or maintain such insurance if the Company
determines in good faith that such insurance is not reasonably available, if
the premium costs for such insurance are disproportionate to the amount of
coverage provided, or if the coverage provided by such insurance is limited by
exclusions so as to provide an insufficient benefit. The Company shall promptly
notify Indemnitee of any good faith determination not to provide such coverage.

 

14.                                 Contract Rights Not Exclusive. 
The rights to payment of Indemnifiable Amounts and advancement of
Indemnifiable Expenses provided by this Agreement shall be in addition to, but
not exclusive of, any other rights which Indemnitee may have at any time under
applicable law, the Company’s Certificate of Incorporation or By-laws, or any
other agreement, vote of stockholders or directors (or a committee of
directors), or otherwise, both as to action in Indemnitee’s official capacity
and as to action in any other capacity as a result of Indemnitee’s 

 

7

 

serving as a  consultant to
the Company in the role of principal financial officer and principal accounting
officer.

 

15.                                 Successors.  This
Agreement shall be (a) binding upon all successors and assigns of the
Company (including any transferee of all or a substantial portion of the
business, stock and/or assets of the Company and any direct or indirect
successor by merger or consolidation or otherwise by operation of law) and (b) binding
on and shall inure to the benefit of the heirs, personal representatives,
executors and administrators of Indemnitee. 
This Agreement shall continue for the benefit of Indemnitee and such
heirs, personal representatives, executors and administrators after Indemnitee
has ceased to have Corporate Status.

 

16.                                 Subrogation. 
In the event of any payment of Indemnifiable Amounts under this
Agreement, the Company shall be subrogated to the extent of such payment to all
of the rights of contribution or recovery of Indemnitee against other persons,
and Indemnitee shall take, at the request of the Company, all reasonable action
necessary to secure such rights, including the execution of such documents as
are necessary to enable the Company to bring suit to enforce such rights.

 

17.                                 Change in Law. 
To the extent that a change in Delaware law (whether by statute or
judicial decision) shall permit broader indemnification or advancement of
expenses  than is provided under the
terms of the By-laws and this Agreement, Indemnitee shall be entitled to such broader
indemnification and advancements, and this Agreement shall be deemed to be
amended to such extent.

 

18.                                 Severability. 
Whenever possible, each provision of this Agreement shall be interpreted
in such a manner as to be effective and valid under applicable law, but if any
provision of this Agreement, or any clause thereof, shall be determined by a
court of competent jurisdiction to be illegal, invalid or unenforceable, in
whole or in part, such provision or clause shall be limited or modified in its application
to the minimum extent necessary to make such provision or clause valid, legal
and enforceable, and the remaining provisions and clauses of this Agreement
shall remain fully enforceable and binding on the parties.

 

19.                                 Indemnitee as Plaintiff. 
Except as provided in Section 10(c) of this Agreement and in
the next sentence, Indemnitee shall not be entitled to payment of Indemnifiable
Amounts or advancement of Indemnifiable Expenses with respect to any Proceeding
brought by Indemnitee against the Company, any Entity which it controls, any
director or officer thereof, or any third party, unless the Board of Directors
of the Company has consented to the initiation of such Proceeding.  This Section shall not apply to
counterclaims or affirmative defenses asserted by Indemnitee in an action
brought against Indemnitee.

 

20.                                 Modifications and Waiver. 
Except as provided in Section 17 above with respect to changes in
Delaware law which broaden the right of Indemnitee to be indemnified by the
Company, no supplement, modification or amendment of this Agreement shall be
binding unless executed in writing by each of the parties hereto.  No waiver of any of the provisions of this
Agreement shall be deemed or shall constitute a waiver of any other provisions
of this Agreement (whether or not similar), nor shall such waiver constitute a
continuing waiver.

 

8

 

21.                                 General Notices. 
All notices, requests, demands and other communications hereunder shall
be in writing and shall be deemed to have been duly given (a) when
delivered by hand, (b) when transmitted by facsimile and receipt is
acknowledged, or (c) if mailed by certified or registered mail with
postage prepaid, on the third business day after the date on which it is so
mailed:

 

(i)            If to Indemnitee, to:

 

Joseph A. Calo

97 Green Street

Medfield, MA 02052

 

(ii)           If to the Company, to:

 

NeuroMetrix, Inc.

62 Fourth Avenue

Waltham, MA  02451

Attention:  President

 

or to
such other address as may have been furnished in the same manner by any party
to the others.

 

22.                                 Governing Law; Consent to Jurisdiction;
Service of Process.  This Agreement shall be governed by and
construed in accordance with the laws of the State of Delaware without regard
to its rules of conflict of laws. 
Each of the Company and the Indemnitee hereby irrevocably and
unconditionally consents to submit to the exclusive jurisdiction of the Court
of Chancery of the State of Delaware and the courts of the United States of
America located in the State of Delaware (the “Delaware Courts”) for any
litigation arising out of or relating to this Agreement and the transactions
contemplated hereby (and agrees not to commence any litigation relating thereto
except in such courts), waives any objection to the laying of venue of any such
litigation in the Delaware Courts and agrees not to plead or claim in any
Delaware Court that such litigation brought therein has been brought in an
inconvenient forum.  Each of the parties
hereto agrees, (a) to the extent such party is not otherwise subject to
service of process in the State of Delaware, to appoint and maintain an agent
in the State of Delaware as such party’s agent for acceptance of legal process,
and (b) that service of process may also be made on such party by prepaid
certified mail with a proof of mailing receipt validated by the United States
Postal Service constituting evidence of valid service.  Service made pursuant to (a) or (b) above
shall have the same legal force and effect as if served upon such party
personally within the State of Delaware. 
For purposes of implementing the parties’ agreement to appoint and
maintain an agent for service of process in the State of Delaware, each such
party does hereby appoint Corporation Service Company, 2711 Centerville Road Suite 400,
Wilmington, New Castle County, Delaware 19808, as such agent and each such
party hereby agrees to complete all actions necessary for such appointment.

 

[signature page follows]

 

9

 

IN WITNESS WHEREOF, the parties hereto have executed this Agreement as
of the day and year first above written.

 

	
   

  	
  NEUROMETRIX, INC.

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By: 

  	
  /s/ Shai N. Gozani, M.D., Ph.D.

  
	
   

  	
  Name:

  	
  Shai N. Gozani, M.D., Ph.D.

  
	
   

  	
  Title:

  	
  President and Chief Executive Officer

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  INDEMNITEE

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  /s/ Joseph A. Calo

  
	
   

  	
  Joseph A. Calo

  
				

 

10Exhibit 4.1

 

PRICING
INSTRUMENT

 

WHEREAS, the parties
named herein desire to enter into certain Program Documents (as defined herein)
contained herein, each such document (unless otherwise specified in such
document) dated as of July 21, 2008, relating to the issuance by Genworth
Global Funding Trust 2008-39  (the “Trust”)
of Notes to investors under the secured notes program sponsored by Genworth
Life and Annuity Insurance Company (“GLAIC”), the terms of such Notes as
specified in the pricing supplement attached to this Pricing Instrument as Exhibit C
(the “Pricing Supplement”);

 

WHEREAS, the Trust is a
trust and will be organized under and its activities will be governed by the
provisions of the Trust Agreement (set forth in Section A of this Pricing
Instrument), dated as of July 21, 2008, by and between the parties thereto
indicated in Section E herein;

 

WHEREAS, certain expense
and indemnification arrangements between GLAIC and the Trustee, on behalf of
itself and on behalf of the Trust, are governed pursuant to the provisions of
the Expense and Indemnity Agreement dated as of October 1, 2006 by and
between GLAIC and the Trustee;

 

WHEREAS, certain
licensing arrangements between the Trust and Genworth Financial, Inc. will
be governed pursuant to the provisions of the License Agreement dated as of October 28,
2005, by and between the Trust and Genworth Financial, Inc.;

 

WHEREAS, certain
custodial arrangements for the Funding Agreement will be governed pursuant to
the provisions of the Custodial Agreement (the “Custodial Agreement”) dated as
of December 7, 2005 by and among SunTrust Bank, acting as custodian (the “Custodian”),
the Indenture Trustee and the Trust;

 

WHEREAS, the Notes will
be issued pursuant to the Indenture (set forth in Section B of this Pricing
Instrument), dated as of the Original Issue Date, by and between the parties
thereto indicated in Section E herein;

 

WHEREAS, the sale of the
Notes will be governed by the Terms Agreement (set forth in Section C of
this Pricing Instrument), dated as of July 21, 2008, by and among the
parties thereto indicated in Section E herein; and

 

WHEREAS, certain
agreements relating to the Notes and the Funding Agreement are set forth in the
Coordination Agreement (set forth in Section D of this Pricing
Instrument), dated as of July 21, 2008, by and among the parties thereto
indicated in Section E herein.

 

All capitalized terms
used herein and not otherwise defined will have the meanings set forth in the
Indenture.

 

1

 

SECTION A

 

TRUST AGREEMENT

 

This TRUST AGREEMENT
(this “Trust Agreement”), dated as of July 21, 2008, is entered into by
and between GSS Holdings II, Inc., a Delaware corporation, as trust
beneficial owner (the “Trust Beneficial Owner”), and U.S. Bank National
Association, a national banking association, as Trustee (the “Trustee”).

 

References
in the Standard Trust Terms to JPMorgan Chase Bank, N.A. shall refer
to The Bank of New York Mellon Trust Company, N.A. and its permitted
successors and assigns.

 

W I T N E S S E T H:

 

WHEREAS, the Trust
Beneficial Owner and the Trustee desire to authorize the issuance of a Trust
Beneficial Interest and a series of Notes in connection with the entry into
this Trust Agreement;

 

WHEREAS, all things
necessary to make this Trust Agreement a valid and legally binding agreement of
the Trustee and the Trust Beneficial Owner, enforceable in accordance with its
terms, have been done;

 

WHEREAS, the parties
intend to provide for, among other things, (i) the issuance and sale of
the Notes (pursuant to the Indenture, the Distribution Agreement and the
related Terms Agreement) and the Trust Beneficial Interest, (ii) the use
of the proceeds of the sale of the Notes and Trust Beneficial Interest to
acquire the Funding Agreement, and (iii) all other actions deemed
necessary or desirable in connection with the transactions contemplated by this
Trust Agreement; and

 

WHEREAS, the parties
hereto desire to incorporate by reference those certain Standard Trust Terms,
dated as of December 8, 2005, and attached to the Pricing Instrument as Exhibit A (the “Standard Trust Terms”).

 

NOW, THEREFORE, in
consideration of the agreements and obligations set forth herein and for other
good and valuable consideration, the sufficiency of which are hereby acknowledged,
each party hereby agrees as follows:

 

ARTICLE 1

 

Section 1.01    Incorporation by Reference.  All terms, provisions and agreements set
forth in the Standard Trust Terms (except to the extent expressly modified
herein) are hereby incorporated herein by reference with the same force and
effect as though fully set forth herein. 
All capitalized terms not otherwise defined herein (including the
recitals hereof) shall have the meanings set forth in the Standard Trust Terms
(the Standard Trust Terms and this Trust Agreement, collectively, the “Trust
Agreement”).  To the extent that the
terms set forth in Article 2 of this Trust Agreement are inconsistent with
the terms of the Standard Trust Terms, the terms set forth in Article 2
herein shall apply.

 

A-1

 

ARTICLE 2

 

Section 2.01    Name.  The
Trust created and governed by this Trust Agreement shall be the trust specified
in the Pricing Instrument.  The name of
the Trust shall be the name specified in the first paragraph of the Pricing
Instrument, as such name may be modified from time to time by the Trustee
following written notice to the Trust Beneficial Owner.

 

Section 2.02    Jurisdiction. 
The Trust is hereby organized in, and formed under and pursuant to, the
laws of the jurisdiction specified in the Pricing Supplement.

 

Section 2.03    Initial Capital Contribution and Ownership.  The Trust Beneficial Owner has paid or has
caused to be paid to, or to an account at the direction of, the Trustee, on the
date hereof, the sum of $15 (or, in the case of Notes issued with original
issue discount, such amount multiplied by the issue price of the Notes as
specified in the Pricing Supplement). 
The Trustee hereby acknowledges receipt in trust from the Trust Beneficial
Owner, as of the date hereof, of the foregoing contribution, which shall be
used along with the proceeds from the sale of the series of Notes to purchase
the Funding Agreement.  Upon the creation
of the Trust and the registration of the Trust Beneficial Interest in the
Securities Register (as defined in the Trust Agreement) by the Trust Registrar
in the name of the Trust Beneficial Owner, the Trust Beneficial Owner shall be
the sole beneficial owner of the Trust.

 

Section 2.04    Acknowledgment. 
The Trustee, on behalf of the Trust, expressly acknowledges its duties
and obligations set forth in the Standard Trust Terms incorporated herein by
reference.

 

Section 2.05    Additional Terms. 
Section 5.01(a) of the Standard Trust Terms is hereby replaced
with the following: “it is a national banking association duly organized,
validly existing and in good standing under the laws of the United States of
America and it is a “bank” within the meaning of Section 581 of the Code;”.

 

Section 2.06    Pricing Instrument; Execution and Incorporation of Terms.

 

The parties hereto will
enter into the Trust Agreement by executing the Pricing Instrument.

 

By executing the Pricing
Instrument, the Trustee and the Trust Beneficial Owner hereby agree that the
Trust Agreement will constitute a legal, valid and binding agreement between
the Trustee and the Trust Beneficial Owner.

 

All terms relating to the
Trust or the series of Notes not otherwise included herein will be as specified
in the Pricing Instrument or Pricing Supplement, as indicated herein.

 

Section 2.07    Governing Law. 
This Trust Agreement will be governed by, and construed in accordance
with, the laws of the jurisdiction specified in the Pricing Supplement.

 

A-2

 

Section 2.08    Counterparts. 
The Trust Agreement, through the Pricing Instrument, may be executed in
any number of counterparts, each of which counterparts shall be deemed to be an
original, and all of which counterparts shall constitute but one and the same
instrument.

 

A-3

 

SECTION B

 

INDENTURE

 

This INDENTURE (this “Indenture”)
is entered into as of the Original Issue Date by and between the Genworth
Global Funding Trust specified in the Pricing Instrument (the “Trust”) and The
Bank of New York Mellon Trust Company, N.A., as the indenture trustee (the “Indenture
Trustee”).

 

The Bank of New York
Mellon Trust Company, N.A., in its capacity as Indenture Trustee, hereby
accepts its role as Registrar, Paying Agent, Transfer Agent and Calculation
Agent hereunder.

 

References herein to “Indenture
Trustee,” “Registrar,” “Transfer Agent,” “Paying Agent” or “Calculation Agent”
shall include the permitted successors and assigns of any such entity from time
to time and references in the Standard Indenture Terms to The Bank of New
York  shall refer to U.S. Bank National
Association and its permitted successors and assigns.

 

W I T N E S S E T H:

 

WHEREAS, the Trust has
duly authorized the execution and delivery of this Indenture to provide for the
issuance of Notes;

 

WHEREAS, all things
necessary to make this Indenture a valid and legally binding agreement of the
Trust and the other parties to this Indenture, enforceable in accordance with
its terms, have been done, and the Trust proposes to do all things necessary to
make the Notes, when executed by the Trust and authenticated and delivered
pursuant hereto, valid and legally binding obligations of the Trust as
hereinafter provided; and

 

WHEREAS, the parties
hereto desire to incorporate by reference those certain Standard Indenture
Terms, dated as of December 8, 2005, and attached to the Pricing
Instrument as Exhibit B (the “Standard
Indenture Terms”).

 

NOW, THEREFORE, for and
in consideration of the premises and the purchase of the Notes by the Holders
thereof, it is mutually covenanted and agreed by each of the parties hereto as
follows:

 

ARTICLE 1

 

Section 1.01    Incorporation by Reference.  All terms, provisions and agreements set
forth in the Standard Indenture Terms (except to the extent expressly modified
herein) are hereby incorporated herein by reference with the same force and
effect as though fully set forth herein. 
All capitalized terms not otherwise defined herein (including the
recitals hereof) shall have the meanings set forth in the Standard Indenture
Terms (the Standard Indenture Terms and this Indenture, collectively, the “Indenture”).  To the extent that the terms set forth in Article 2
of this Indenture are inconsistent with the terms of the Standard Indenture
Terms, the terms set forth in Article 2 herein shall apply.

 

B-1

 

ARTICLE 2

 

Section 2.01    Agreement to be Bound.  Each of the Trust, the Indenture Trustee, the
Registrar, the Transfer Agent, the Paying Agent and the Calculation Agent
hereby agrees to be bound by all of the terms, provisions and agreements set
forth in the Indenture, with respect to all matters contemplated in the
Indenture, including, without limitation, those relating to the issuance of the
below-referenced Notes.

 

Section 2.02    Designation of the Trust, the Notes and the Funding
Agreement.  The Trust created
by the Trust Agreement specified in the Pricing Instrument and referred to
herein is the Genworth Global Funding Trust specified in the Pricing
Instrument.  The Notes issued by the
Trust and governed by the Indenture shall be the Notes specified in the Pricing
Supplement.  The Funding Agreement designated
hereby is the Funding Agreement designated in the Pricing Supplement, effective
as of the Original Issue Date, between the Trust and Genworth Life and Annuity
Insurance Company.

 

Section 2.03    Additional Terms. Notwithstanding anything to the
contrary in Section 2.04(c) of the Standard Indenture Terms, the
Indenture Trustee will give written notice of redemption to the Holders in
accordance with Section 1.06 of the Standard Indenture Terms not more than
seventy-five (75) calendar days and not less than thirty (30) calendar days
prior to the date set for such redemption. Notwithstanding anything to the
contrary in Section 2.04(f) of the Standard Indenture Terms, the
Indenture Trustee shall treat as satisfactory to it thirty-five (35) calendar
days’ notice from the Trust (or from GLAIC on behalf of the Trust) of a
redemption date for the Notes; provided that there are at least three Business
Days between the receipt by it of such notice and the deadline for giving
notice of such redemption under Section 2.04(c); provided further that the
Notes are in the form of Global Notes and the redemption is in whole.  The initial principal amount of the Notes
shall be $1,738,000.00.

 

Section 2.04    Pricing Instrument; Execution and Incorporation of Terms.

 

The parties hereto will
enter into this Indenture by executing the Pricing Instrument.

 

By executing the Pricing
Instrument, the Indenture Trustee, the Registrar, the Transfer Agent, the
Paying Agent, the Calculation Agent and the Trust hereby agree that the
Indenture will constitute a legal, valid and binding agreement between the
Indenture Trustee, the Registrar, the Transfer Agent, the Paying Agent, the
Calculation Agent and the Trust.

 

All terms relating to the
Trust or the Notes not otherwise included herein will be as specified in the
Pricing Instrument or Pricing Supplement, as indicated herein.

 

Section 2.05    Counterparts. 
This Indenture, through the Pricing Instrument, may be executed in any
number of counterparts, each of which counterparts shall be deemed to be an
original, and all of which counterparts shall constitute one and the same
instrument.

 

[Remainder
of Page Left Intentionally Blank]

 

B-2

 

SECTION C

 

TERMS AGREEMENT

 

This TERMS AGREEMENT
(this “Terms Agreement”) is entered into as of July 21, 2008 by and among
Genworth Life and Annuity Insurance Company (“GLAIC”), the Genworth Global
Funding Trust specified in the Pricing Instrument (the “Trust”) and the Agent
specified in the Pricing Supplement (the “Agent”).

 

W I T N E S S E T H:

 

WHEREAS, GLAIC and the
Agent have entered into that certain Distribution Agreement dated December 9,
2005 (the “Distribution Agreement”).

 

NOW, THEREFORE, in
consideration of the mutual promises set forth herein and other good and
valuable consideration, the sufficiency and receipt of which are hereby
acknowledged, each of the parties hereby agrees as follows:

 

ARTICLE 1

 

Section 1.01    Incorporation by Reference.  The provisions of the Distribution Agreement
and the related definitions (unless otherwise specified herein) are
incorporated by reference herein and shall be deemed to have the same force and
effect as if set forth in full herein.

 

ARTICLE 2

 

Section 2.01    Addition of Trust as Party to Distribution Agreement.

 

Pursuant to Section 1
of the Distribution Agreement, each of the undersigned parties hereby
acknowledges and agrees that the Trust, upon execution hereof by the Trust and
the other parties to this Terms Agreement, shall become a Trust for purposes of
the Distribution Agreement in accordance with the terms thereof, in respect of
the Notes, with all the authority, rights, powers, duties and obligations of a
Trust under the Distribution Agreement. 
The Trust confirms that any agreement, covenant, acknowledgment,
representation or warranty under the Distribution Agreement applicable to the
Trust is made by the Trust at the date hereof, unless another time or times are
specified in the Distribution Agreement, in which case such agreement,
covenant, acknowledgment, representation or warranty shall be deemed to be
confirmed by the Trust at such specified time or times.

 

All references to Section 9
(Indemnification) of the Distribution Agreement to “solely with respect to the
applicable Agent(s) or Co-Agent(s)” will include all of such Agent’s or
Co-Agent’s directors and officers and each person, if any, who controls such
Agent or Co-Agent within the meaning of Section 15 of the Securities Act
of 1933, as amended or Section 20 of the Securities Exchange Act of 1934,
as amended.  All references in the
Distribution Agreement to the “Registration Statement”, the “Institutional Base
Prospectus”, the “Retail Base Prospectus”, any “preliminary prospectus”, the “Time
of Sale Prospectus” and the “Prospectus” shall also be deemed to include all
documents incorporated by reference therein.

 

C-1

 

Section 2.02    Purchase of Notes as Principal.

 

(a)    Subject
in all respects to the terms and conditions of the Distribution Agreement, the
Trust hereby agrees to sell to the Agent and the Agent hereby agrees to
purchase the Notes having the terms specified in the Pricing Supplement
relating to such Notes. The initial principal amount of the Notes is
$1,738,000.00.

 

(b)    In
connection with any purchase of Notes from the Trust by the Agent as principal,
the parties agree that the items specified on Schedule I of the Pricing
Instrument will be delivered as of the Settlement Date.

 

Section 2.03    Termination. 
Upon the termination of this Terms Agreement pursuant to Section 13(b) of
the Distribution Agreement the undersigned parties hereby agree to allocate the
expenses reasonably incurred prior to or in connection with such termination as
follows:

 

The expenses will be
borne by GLAIC.

 

Section 2.04    Applicable
Time.  For purposes of the
Distribution Agreement, the Applicable Time shall be 2:17 pm EST, July 21,
2008.

 

Section 2.05    Governing Law. 
This Terms Agreement shall be governed by and construed in accordance
with the laws of the State of New York without regard to the principles of
conflicts of laws thereof.

 

Section 2.06    Notices. For purposes of Section 14 of the
Distribution Agreement, the Trust’s communications details are as set forth in Section D
of the Pricing Instrument.

 

Section 2.07  Additional Terms.  The Agent represents, warrants and covenants
with or to (as the case may be) the Trust and the Company that it has not
offered, sold or delivered and it will not offer, sell or deliver, any of the
Notes, in or from any jurisdiction except under circumstances that are
reasonably designed to result in compliance with the applicable securities laws
and regulations thereof.

 

Section 2.08    Pricing Instrument; Execution and Incorporation of Terms.

 

The parties hereto will
enter into this Terms Agreement by executing the Pricing Instrument.

 

By executing the Pricing
Instrument, each party hereto agrees that this Terms Agreement will constitute
a legal, valid and binding agreement by and among such parties.

 

All terms relating to the
Trust or the Notes not otherwise included in this Terms Agreement will be as
specified in the Pricing Instrument or Pricing Supplement, as indicated herein.

 

Section 2.09    Counterparts. 
This Terms Agreement, through the Pricing Instrument, may be executed in
any number of counterparts, each of which counterparts shall be deemed to be an
original, and all of which counterparts shall constitute but one and the same
instrument.

 

C-2

 

SECTION D

 

COORDINATION AGREEMENT

 

This COORDINATION
AGREEMENT (this “Coordination Agreement”), dated as of July 21, 2008, is
entered into by and among Genworth Life and Annuity Insurance Company (“GLAIC”),
the Genworth Global Funding Trust specified in the Pricing Instrument (the “Trust”),
SunTrust Bank, in its capacity as custodian of the Funding Agreement (“Custodian”)
and The Bank of New York Mellon Trust Company, N.A., as the indenture trustee
(the “Indenture Trustee”).

 

W I T N E S S E T H

 

WHEREAS, the Trust will
enter into the Funding Agreement with GLAIC, effective as of the Original Issue
Date specified in the Pricing Supplement;

 

WHEREAS, the Agents (as
defined in the Distribution Agreement) will sell the Notes in accordance with
the Registration Statement;

 

WHEREAS, the Trust
intends to issue the Notes in accordance with the Indenture, to collaterally
assign to, and grant a security interest in, the Funding Agreement to and in
favor of the Indenture Trustee in accordance with the Indenture to secure
payment of the Notes; and

 

WHEREAS, the Custodian
will hold the Funding Agreement on behalf of the Indenture Trustee pursuant to
the terms of the Custodial Agreement.

 

NOW, THEREFORE, to give
effect to the agreements and arrangements established under the Terms Agreement
included in the Pricing Instrument, as applicable, the Trust Agreement, the
Indenture and the Notes, and in consideration of the agreements and obligations
set forth herein and for other good and valuable consideration, the sufficiency
of which are hereby acknowledged, each party hereby agrees as follows:

 

ARTICLE 1

 

Section 1.01    Delivery of the Funding Agreement.  The Trust hereby authorizes the Custodian, on
behalf of the Indenture Trustee, to receive the Funding Agreement from GLAIC
pursuant to the assignment of the Funding Agreement (the “Assignment”), to be
entered into on the Original Issue Date, included in the closing instrument
dated as of the Original Issue Date (the “Closing Instrument”).

 

Section 1.02  Issuance and
Purchase of the Notes.

 

(a)           Delivery of the Funding Agreement to
the Custodian, on behalf of the Indenture Trustee, pursuant to the Assignment
or execution of the cross-receipt contained in the Closing Instrument shall be
confirmation of payment by the Trust for the Funding Agreement.

 

(b)           The Trust hereby directs the
Indenture Trustee, upon receipt of the Funding Agreement by the Custodian, on
behalf of the Indenture Trustee and pursuant to the Assignment, 

 

D-1

 

(i) to authenticate the certificates representing
the Notes (the “Certificates”) in accordance with the Indenture and (ii) to
(A) deliver each relevant Certificate to the clearing system or systems
identified in each such Certificate, or to the nominee of such clearing system,
or the custodian thereof, for credit to such accounts as the Agent may direct,
or (B) deliver each relevant Certificate to the purchasers thereof as
identified by the Agent.

 

ARTICLE 2

 

Section 2.01    Directions Regarding Periodic Payments.  As registered owner of the Funding Agreement
as collateral securing payments on the Notes, the Indenture Trustee will
receive payments on the Funding Agreement on behalf of the Trust.  The Trust hereby directs the Indenture
Trustee to use such funds to make payments on behalf of the Trust pursuant to
the Trust Agreement and the Indenture.

 

Section 2.02    Maturity of the Funding Agreement.  Upon the maturity of the Funding Agreement
and the return of funds thereunder, the Trust hereby directs the Indenture
Trustee to set aside from such funds an amount sufficient for the repayment of
the outstanding principal on the Notes and Trust Beneficial Interest when due.

 

ARTICLE 3

 

Section 3.01    Officer’s Certificates.  GLAIC hereby agrees to deliver an Officer’s
Certificate, a copy of which is attached hereto as Exhibit D,
on a quarterly basis to any rating agency currently rating the Program.  The Trust hereby agrees to deliver an Officer’s
Certificate, a copy of which is attached to the Pricing Instrument as Exhibit E, on a quarterly basis to any
rating agency currently rating the Program.

 

Section 3.02    Filings. 
GLAIC hereby covenants to file, or cause to be filed, in a timely manner
on behalf of the Trust all reports, certifications or similar filings required
under the Securities Exchange Act of 1934, as amended.

 

ARTICLE 4

 

Section 4.01    No Additional Liability.  Nothing in this Coordination Agreement shall
impose any liability or obligation on the part of any party to this
Coordination Agreement to make any payment or disbursement in addition to any
liability or obligation such party has under the Program Documents, except to
the extent that a party has actually received funds which it is obligated to
disburse pursuant to this Coordination Agreement.

 

Section 4.02    No Conflict. 
This Coordination Agreement is intended to be in furtherance of the
agreements reflected in the documents related to the Program Documents, and not
in conflict.  To the extent that a
provision of this Coordination Agreement conflicts with the provisions of one
or more Program Documents, the provisions of such Program Documents shall
govern.

 

Section 4.03    Governing Law. 
This Coordination Agreement shall be governed by and construed in
accordance with the laws of the State of New York without regard to the
principles of conflicts of laws thereof.

 

D-2

 

Section 4.04    Severability. 
If any provision in this Coordination Agreement shall be invalid,
illegal or unenforceable, such provision shall be deemed severable from the
remaining provisions of this Coordination Agreement and shall in no way affect
the validity or enforceability of such other provisions of this Coordination
Agreement.

 

Section 4.05    Notices. 
All demands, notices and communications under this Coordination
Agreement shall be in writing and shall be deemed to have been duly given upon
receipt at the addresses set forth below:

 

To the Trust:

 

Genworth Global Funding Trust 2008-39 

c/o U.S. Bank National Association

Corporate Trust Services

209 S. LaSalle Street, Suite 300

Chicago, Illinois 60604

Attention:  Patricia Child, VP

Facsimile: (312) 325-8905

 

To the Indenture Trustee:

 

The Bank of New
York Mellon Trust Company, N.A.

2 North LaSalle Street, Suite 1020

Chicago, Illinois 60602

Attention: Corporate Finance

Facsimile: (312) 827-8542

 

To GLAIC:

 

Genworth Life and
Annuity Insurance Company

6610 West Broad Street

Richmond, Virginia 23230

Attention: Treasurer

Facsimile: (804) 662-7777

 

with a copy to:

 

Genworth Life and
Annuity Insurance Company

6610 West Broad Street

Richmond, Virginia 23230

Attention: Heather Harker, Esq.

Facsimile: (804) 281-6005

 

To the Custodian:

 

SunTrust
Bank

919 East Main Street

Richmond,
Virginia 23219

Attention: Retirement Services

Facsimile:
(804) 782-7439

 

D-3

 

or at such other address as shall be designated by any
such party in a written notice to the other parties.

 

ARTICLE 5

 

Section 5.01    Pricing Instrument; Execution and Incorporation of Terms.

 

The parties to this
Coordination Agreement will enter into this Coordination Agreement by executing
the Pricing Instrument.

 

By executing the Pricing
Instrument, each party hereto agrees that this Coordination Agreement will
constitute a legal, valid and binding agreement by and among the Trust, GLAIC,
the Custodian and the Indenture Trustee.

 

All terms relating to the
Trust or the Notes not otherwise included in this Coordination Agreement will
be as specified in the Pricing Instrument or Pricing Supplement, as indicated
herein.

 

Section 5.02    Counterparts. 
This Coordination Agreement, through the Pricing Instrument, may be
executed in any number of counterparts, each of which counterparts shall be
deemed to be an original, and all of which counterparts shall constitute but
one and the same instrument.

 

Section 5.03    Capitalized Terms.  All capitalized terms used herein and not
otherwise defined in this Coordination Agreement will have the meanings set
forth in the Indenture.

 

[Remainder
of Page Left Intentionally Blank]

 

D-4

 

SECTION E

 

MISCELLANEOUS AND
EXECUTION PAGES

 

This Pricing Instrument may be executed by each of the
parties hereto in any number of counterparts, and by each of the parties hereto
on separate counterparts, each of which counterparts, when so executed and
delivered, shall be deemed to be an original, but all such counterparts shall
together constitute but one and the same instrument.

 

Each signatory, by its execution hereof, does hereby
become a party to each of the agreements or indenture identified for such party
as of the date specified in such agreements or indenture.

 

IN WITNESS WHEREOF, the undersigned have executed this
Pricing Instrument with respect to the Notes as of the date first written
above.

 

 

	
   

  	
   

  	
  GENWORTH LIFE AND ANNUITY INSURANCE COMPANY (in executing below
  agrees and becomes a party to (i) the Terms Agreement set forth in
  Section C herein and (ii) the Coordination Agreement set forth in Section D
  herein)

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
  By:

  	
           /s/
  Pamela C. Asbury

  
	
   

  	
   

  	
   

  	
  Name:  Pamela
  C. Asbury

  
	
   

  	
   

  	
   

  	
  Title:  Vice
  President

  

 

E-1

 

	
   

  	
   

  	
  THE GENWORTH GLOBAL
  FUNDING TRUST DESIGNATED IN THIS PRICING INSTRUMENT (in executing below
  agrees and becomes a party to (i) the Indenture set forth in
  Section B herein, (ii) the Terms Agreement set forth in
  Section C herein and (iii) the Coordination Agreement set forth in
  Section D herein)

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
  By: U.S. BANK NATIONAL
  ASSOCIATION, not in its individual capacity but solely in its capacity as
  Trustee of  the Trust

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
  By:

  	
          /s/
  Patricia M. Child 

  
	
   

  	
   

  	
   

  	
  Name: Patricia M. Child

  
	
   

  	
   

  	
   

  	
  Title:  Vice President

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  U.S. BANK NATIONAL
  ASSOCIATION (in executing below agrees and becomes a party to the Trust
  Agreement set forth in Section A herein), as Trustee

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  By:

  	
          /s/
  Patricia M. Child 

  
	
   

  	
   

  	
   

  	
  Name: Patricia M. Child

  
	
   

  	
   

  	
   

  	
  Title:  Vice
  President

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  U.S. BANK NATIONAL
  ASSOCIATION (in executing below acknowledges and agrees to Section 5.01
  of the Trust Agreement as set forth in and amended by Section A herein),
  in its individual capacity

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  By

  	
          /s/
  Patricia M. Child 

  
	
   

  	
   

  	
   

  	
  Name: Patricia M. Child

  
	
   

  	
   

  	
   

  	
  Title:  Vice
  President

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  GSS HOLDINGS II, INC.
  (in executing below agrees and becomes a party to the Trust Agreement set
  forth in Section A herein), as Trust Beneficial Owner

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  By:

  	
            /s/
  Bernard J. Angelo  

  
	
   

  	
   

  	
   

  	
  Name: Bernard J. Angelo

  
	
   

  	
   

  	
   

  	
  Title:  Vice President

  

 

E-2

 

	
   

  	
   

  	
  THE BANK OF NEW YORK
  MELLON TRUST COMPANY, N.A. (in executing below agrees and becomes a party to
  (i) the Indenture set forth in Section B herein, as Indenture
  Trustee, Registrar, Transfer Agent, Paying Agent and Calculation Agent and
  (ii) the Coordination Agreement set forth in Section D herein), as
  Indenture Trustee, Registrar, Transfer Agent, Paying Agent and Calculation
  Agent

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  By:

  	
            /s/
  R. Tarnas 

  
	
   

  	
   

  	
   

  	
  Name: R. Tarnas

  
	
   

  	
   

  	
   

  	
  Title:  Vice President

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  SUNTRUST BANK (in
  executing below agrees and becomes a party to the Coordination Agreement set
  forth in Section D herein), as Custodian

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  By:

  	
            /s/
  Richard J. Owens, III

  
	
   

  	
   

  	
   

  	
  Name: Richard J. Owens, III

  
	
   

  	
   

  	
   

  	
  Title: 
  VP/Trust Officer

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  INCAPITAL,
  LLC (in executing below agrees and becomes a party to the Terms Agreement set
  forth in Section C herein)

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  By:

  	
            /s/
  Brian Walker

  
	
   

  	
   

  	
   

  	
  Name: Brian Walker

  
	
   

  	
   

  	
   

  	
  Title: Managing Director

  

 

E-3

 

EXHIBIT A

Standard Trust Terms

 

As filed as Exhibit 4.5 to the Registration Statement on Form S-3
(File No. 333-128718), filed by Genworth Life and Annuity Insurance
Company with the Securities and Exchange Commission (the “Commission”) on September 30,
2005, as amended by Amendment No. 1, filed with the Commission on December 8,
2005.

 

A-1

 

EXHIBIT B

Standard Indenture Terms

 

As filed as Exhibit 4.1 to the Registration Statement on Form S-3
(File No. 333-128718), filed by Genworth Life and Annuity Insurance
Company with the Securities and Exchange Commission (the “Commission”) on September 30,
2005, as amended by Amendment No. 1, filed with the Commission on December 8,
2005.

 

B-1

 

EXHIBIT C

Pricing Supplement

 

As filed with the Securities and Exchange Commission pursuant to Rule 424(b) under
the Securities Act, dated as of July 14, 2008, with respect to the Notes
to be issued by the Trust.

 

C-1

 

EXHIBIT D

Genworth Life and Annuity Insurance Company

 

Officer’s
Certificate

 

The undersigned, an officer of Genworth Life and
Annuity Insurance Company, a stock life insurance company operating under a
charter granted by the Commonwealth of Virginia (“GLAIC”), does hereby certify
to Standard & Poor’s Ratings Services, a division of The McGraw-Hill
Companies, Inc., in such capacity and on behalf of GLAIC, to the knowledge
of the undersigned and after reasonable inquiry, that:

 

	
  1.

  	
   

  	
  each of the
  representations and warranties of GLAIC contained in each Expense and
  Indemnity Agreement entered into in connection with the Registration
  Statement (defined below), and each Funding Agreement issued in connection
  with the Program (the “Specified Agreements”) (other than any representation
  or warranty expressly made as of a date prior to the date hereof) are true
  and correct on and as of the date hereof, with the same effect as though such
  representation or warranty had been made on and as of the date hereof;

  
	
   

  	
   

  	
   

  
	
  2.

  	
   

  	
  no default under any of
  the Specified Agreements and no event or any condition which, with notice or
  lapse of time or both, would become a default, has occurred and is continuing
  as of the date hereof;

  
	
   

  	
   

  	
   

  
	
  3.

  	
   

  	
  GLAIC has performed and
  complied with, in all material respects, all of the agreements, covenants,
  obligations and conditions applicable to GLAIC required by the Specified
  Agreements to be performed or complied with by GLAIC on or before the date
  hereof;

  
	
   

  	
   

  	
   

  
	
  4.

  	
   

  	
  the Registration
  Statement filed on Form S-3 (File No. 333-128718) (the
  “Registration Statement”) by GLAIC has been declared effective by the
  Securities and Exchange Commission (the “Commission”) under the Securities
  Act of 1933, as amended (the “Act”) and no stop order suspending the
  effectiveness of the Registration Statement has been issued and no
  proceedings for that purpose have been commenced by or are pending before or
  contemplated by the Commission;

  
	
   

  	
   

  	
   

  
	
  5.

  	
   

  	
  all filings, if any,
  required by Rule 424 and Rule 430A under the Act have been made in
  a timely manner;

  
	
   

  	
   

  	
   

  
	
  6.

  	
   

  	
  since [·](1),
  the Trusts organized in connection with the program contemplated by the
  Registration Statement have issued the following series of Notes:

  
	
   

  	
   

  	
   

  
	
   

  	
  [List each series of Notes]  [(collectively, the “Designated Notes”)];
  and

  
	
   

  	
   

  	
   

  
	
  7.

  	
   

  	
  the Funding Agreements issued in connection with the
  Designated Notes have been executed and delivered by GLAIC in accordance with
  the terms and conditions of the Program Documents.

  

 

(1) This certificate to be signed quarterly.

 

D-1

 

Capitalized terms used herein and not otherwise
defined herein shall have the meanings set forth in the Standard Indenture
Terms attached as Exhibit 4.1 to the Registration Statement.

 

IN WITNESS WHEREOF, the undersigned has executed this
Certificate as of the [·] day of [·]
200[·].

 

	
   

  	
  [Name], in [his/her]
  capacity as an authorized officer of 

  Genworth Life and Annuity Insurance Company

  
	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
   

  
	
   

  	
   

  	
  Name:

  
	
   

  	
   

  	
  Title:

  

 

D-2

 

EXHIBIT E 

Genworth Global Funding Trusts

 

Trustee
Officer’s Certificate

 

U.S. Bank National Association, not in its individual
capacity but solely in its capacity as trustee acting on behalf of each common
law trust organized under the laws of the State of Illinois (in such capacity,
the “Trustee,” and each such common law trust being referred to herein as a “Trust”)
in connection with the program contemplated by the Registration Statement filed
on Form S-3 (File No. 333-128718) by Genworth Life and Annuity
Insurance Company with the Securities and Exchange Commission (the “Commission”)
on September 30, 2005, as amended by Amendment No. 1, filed with the
Commission on December 8, 2005 (the “Registration Statement”), does hereby
certify to Standard & Poor’s Ratings Services, a division of The
McGraw-Hill Companies, Inc., in such capacity and on behalf of each Trust,
to the knowledge of the Trustee without any independent investigation, that; as
of October 1, 2006:

 

	
  1.

  	
   

  	
  each of the representations and warranties of each
  Trust contained in the Notes issued in connection with the Program, each
  Indenture entered into in connection with the Registration Statement and the
  Expense and Indemnity Agreement concerning the Trusts (the “Specified
  Agreements”) (other than any representation or warranty expressly made as of
  a date prior to the date hereof) are true and correct on and as of the date
  hereof, with the same effect as though such representation or warranty had
  been made on and as of the date hereof;

  
	
   

  	
   

  	
   

  
	
  2.

  	
   

  	
  no default under any of the Specified Agreements and
  no event or any condition which, with notice or lapse of time or both, would
  become a default, has occurred and is continuing as of the date hereof;

  
	
   

  	
   

  	
   

  
	
  3.

  	
   

  	
  each Trust has performed and complied with, in all
  material respects, all of the agreements, covenants, obligations and
  conditions applicable to such Trust required by the Specified Agreements to
  be performed or complied with by such Trust on or before the date hereof;

  
	
   

  	
   

  	
   

  
	
  4.

  	
   

  	
  the Notes issued in connection with the Program have
  been issued, in all material respects, in accordance with the terms and
  conditions of the Program Documents; and

  
	
   

  	
   

  	
   

  
	
  5.

  	
   

  	
  each Funding Agreement has been executed and
  delivered by the related Trust in accordance with the terms and conditions of
  the Program Documents.

  

 

Capitalized terms used herein and not otherwise
defined herein shall have the meanings set forth in the Standard Indenture
Terms attached as Exhibit 4.1 to the Registration Statement. In no event
shall U.S. Bank National Association in its personal corporate capacity (or any
officer of the Trustee in his or her personal capacity) have any liability for
any of the certifications or statements contained in this Trustee Officer’s
Certificate, such liability being solely that of each Trust.

 

E-1

 

IN WITNESS WHEREOF, the undersigned has executed this
Certificate as of the [·] day of [·],
200[·].

 

	
   

  	
  U.S. Bank National
  Association, not in its individual capacity but solely in its capacity as
  Trustee acting on behalf of each Trust

  
	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
   

  
	
   

  	
   

  	
  Name:

  
	
   

  	
   

  	
  Title:

  

 

E-2

 

SCHEDULE
I

 

Terms
Agreement Specifications

 

In
connection with Section 3(a)(iv) of the Distribution Agreement, the
Program under which the Notes are issued is rated Aa3 by Moody’s Investors
Service, Inc. (“Moody’s”) and AA- by Standard & Poor’s Rating
Services, a division of The McGraw-Hill Companies, Inc. (“S&P”).  Genworth Life and Annuity Insurance Company (“GLAIC”)
expects that the Notes will be rated Aa3 by Moody’s and AA- by S&P.  GLAIC’s financial strength rating is Aa3 by
Moody’s and AA- by S&P.

 

In
accordance with Section 2.02(b) of the Terms Agreement and in
connection with the purchase of Notes from the Trust by the Agent, the
following items will be delivered on or prior to the Settlement Date to the
Agent:  None.

 

All capitalized terms used herein and not otherwise
defined herein will have the meanings set forth in the Distribution Agreement.

 

I-1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00145-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00145-of-00352.parquet"}]]